Lisata Therapeutics, Inc.
LSTA · NASDAQ · USD
$1.04
−0.16 −13.33%todayNot financial advice.
- Open
- 1.28
- Day range
- 1.02 - 1.28
- 52-week range
- 0.9875 - 5.07
- Volume
- 180.68K
- Market cap
- 9.37M
- P/E ratio
- —
- EPS
- -1.64
- Dividend yield
- 0.00%
- Beta
- -1.38
Performance
W
−30.20%
1M
−44.09%
3M
−69.32%
6M
−79.28%
YTD
−44.97%
Y
−57.38%
5Y
−94.12%
All
−100.00%
In the news
Oct 8
Lisata Therapeutics Secures New U.S. Patent for Cancer Treatment Certepetide
Lisata Therapeutics secured a U.S. patent for certepetide in solid tumors, extending potential market exclusivity for the clinical asset into 2043.
Company news
Oct 8
Lisata Therapeutics Granted US Patent for Cancer Drug Certepetide
Lisata Therapeutics has secured a U.S. patent for its cancer drug candidate certepetide, extending market exclusivity into 2043.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-LSTA" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Lisata Therapeutics, Inc. (LSTA) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-LSTA">LSTA stock price</a> by FreeTheAI Stocks</p>